agilon health (NYSE:AGL) Price Target Raised to $3.50 at Royal Bank of Canada

agilon health (NYSE:AGL - Get Free Report) had its price target hoisted by analysts at Royal Bank of Canada from $3.00 to $3.50 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Royal Bank of Canada's price target would indicate a potential upside of 12.18% from the stock's current price.

A number of other research analysts have also weighed in on AGL. Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and lifted their price target for the company from $1.75 to $2.25 in a research note on Friday, January 10th. TD Cowen lowered their price objective on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a report on Monday, November 11th. William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Friday, November 8th. Stifel Nicolaus lifted their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday. Finally, Barclays lowered their price objective on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, agilon health currently has a consensus rating of "Hold" and an average price target of $3.95.

agilon health Stock Down 6.9 %

AGL traded down $0.23 during trading on Wednesday, reaching $3.12. The company had a trading volume of 6,347,607 shares, compared to its average volume of 5,615,979. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a 12 month low of $1.50 and a 12 month high of $7.73. The business's fifty day moving average price is $2.96 and its 200 day moving average price is $3.01. The company has a market cap of $1.29 billion, a P/E ratio of -3.32 and a beta of 0.67.

Insider Buying and Selling at agilon health

In other agilon health news, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company's stock, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 77,500 shares of company stock worth $169,600 over the last ninety days. Insiders own 3.20% of the company's stock.

Institutional Investors Weigh In On agilon health

Institutional investors have recently modified their holdings of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in agilon health by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company's stock worth $1,516,000 after purchasing an additional 157,610 shares during the period. Two Sigma Advisers LP lifted its position in agilon health by 4,393.5% during the fourth quarter. Two Sigma Advisers LP now owns 480,800 shares of the company's stock worth $914,000 after purchasing an additional 470,100 shares during the period. Two Sigma Investments LP lifted its position in agilon health by 73.7% during the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company's stock worth $1,630,000 after purchasing an additional 363,855 shares during the period. State of Wyoming lifted its position in agilon health by 89.3% during the fourth quarter. State of Wyoming now owns 122,504 shares of the company's stock worth $233,000 after purchasing an additional 57,802 shares during the period. Finally, Point72 Asset Management L.P. bought a new position in shares of agilon health in the fourth quarter worth about $768,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.